Skip to content

The correlation between secondary renal damage and arterial stiffness in elderly people

The correlation between secondary renal damage and arterial stiffness in elderly people

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041128
Enrollment
Unknown
Registered
2020-12-19
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal damage in elderly patients with hypertension

Interventions

normal baPWV group and abnormal baPWV group:Nil

Sponsors

Tianjin First Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. Patients over 60 years old; 2. Patients diagnosed with essential hypertension according to the European hypertension management guidelines 2018; 3. Patients who signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with primary renal damage (short course of hypertension; simple renal hematuria or proteinuria with hematuria; rapid deterioration of renal function in a short time; sudden edema and large amount of proteinuria with normal renal function; combined with obvious abnormal tube type); 2. Patients with immune system diseases and thyroid dysfunction; 3. Patients with secondary hypertension, malignant hypertension and hypertension emergency; 4. Patients with diabetes, coronary heart disease, peripheral vascular disease, rheumatic heart disease, congenital heart disease, etc; 5. Patients with severe cardiac insufficiency, severe liver and kidney insufficiency; 6. Patients taking nephrotoxic drugs for a long time; 7. Patients with recent cerebral hemorrhage, urinary system diseases, severe infection, etc.

Design outcomes

Primary

MeasureTime frame
pulse wave velocity;creatinine;urine microalbumin;Glomerular filtration rate;Urinary microalbumin / creatinine ratio;Urea nitrogen;Serum cystatin C;

Secondary

MeasureTime frame
Homocysteine;

Countries

China

Contacts

Public ContactWang Xuena

Tianjin First Central Hospital

824486605@qq.com+86 13602101573

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026